HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumiyoshi Yamashita Selected Research

Therapeutics

11/2020Biosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography.
4/2019Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
6/2015Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model.
11/2014Enhancement of the anti-tumor effect of DNA vaccination using an ultrasound-responsive mannose-modified gene carrier in combination with doxorubicin-encapsulated PEGylated liposomes.
8/2014Preparation of immunostimulatory single-walled carbon nanotube/CpG DNA complexes and evaluation of their potential in cancer immunotherapy.
6/2014Tumour-associated macrophages targeted transfection with NF-κB decoy/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice.
1/2014Photothermal ablation of tumor cells using a single-walled carbon nanotube-peptide composite.
1/2014Inhibition of cancer cell growth by GRP78 siRNA lipoplex via activation of unfolded protein response.
4/2011Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier.
1/2011Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumiyoshi Yamashita Research Topics

Disease

48Neoplasms (Cancer)
11/2020 - 04/2002
19Neoplasm Metastasis (Metastasis)
09/2013 - 04/2002
12Melanoma (Melanoma, Malignant)
07/2020 - 11/2004
5Inflammation (Inflammations)
11/2014 - 02/2007
5Carcinoma (Carcinomatosis)
08/2014 - 05/2002
4Hepatocellular Carcinoma (Hepatoma)
04/2007 - 02/2003
3Breast Neoplasms (Breast Cancer)
04/2019 - 08/2010
3Reperfusion Injury
01/2016 - 01/2008
2Adenocarcinoma
12/2019 - 08/2008
2Adenocarcinoma of Lung
01/2016 - 01/2016
2Acute Liver Failure (Fulminant Hepatic Failure)
04/2014 - 01/2006
2Ischemia
07/2012 - 01/2008
2Body Weight (Weight, Body)
05/2009 - 01/2004
2Colonic Neoplasms (Colon Cancer)
09/2007 - 09/2006
2Lung Neoplasms (Lung Cancer)
11/2006 - 02/2006
1Polymorphic catecholergic ventricular tachycardia
01/2022
1Drug-Related Side Effects and Adverse Reactions
09/2021
1Communicable Diseases (Infectious Diseases)
11/2020
1Hyperthermia
07/2020
1HIV Infections (HIV Infection)
09/2019

Drug/Important Bio-Agent (IBA)

18Liposomes (Liposome)IBA
11/2014 - 04/2002
12CatalaseIBA
02/2012 - 05/2002
11DNA (Deoxyribonucleic Acid)IBA
11/2014 - 07/2007
8Peptides (Polypeptides)IBA
04/2019 - 04/2006
8catalase-polyethylene glycolIBA
09/2013 - 05/2002
8Firefly LuciferasesIBA
09/2013 - 11/2004
7Pharmaceutical PreparationsIBA
04/2019 - 09/2006
7Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2016 - 11/2004
7LuciferasesIBA
09/2013 - 11/2004
7Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2013 - 01/2006
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 11/2006
6CytokinesIBA
11/2014 - 09/2003
5SolutionsIBA
04/2019 - 09/2007
5NF-kappa B (NF-kB)IBA
01/2014 - 02/2007
4Dendrimers (Dendrons)IBA
01/2016 - 12/2006
4LipidsIBA
11/2014 - 04/2006
4LipopolysaccharidesIBA
11/2014 - 06/2006
4DNA VaccinesIBA
11/2014 - 07/2007
4Mannose (D-Mannose)IBA
11/2014 - 04/2011
4Small Interfering RNA (siRNA)IBA
09/2014 - 07/2012
4Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2014 - 02/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2019 - 11/2014
3Indicators and Reagents (Reagents)IBA
07/2018 - 11/2004
3Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2014
3Alanine Transaminase (SGPT)IBA
01/2016 - 01/2008
3Messenger RNA (mRNA)IBA
01/2014 - 07/2006
3EmulsionsIBA
05/2009 - 09/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2006 - 09/2003
2diazonaphthalenedisulfonic acid (NDS)IBA
07/2020 - 12/2019
2LigandsIBA
01/2017 - 09/2006
2Amino AcidsFDA Link
01/2016 - 08/2010
2Lysine (L-Lysine)FDA Link
01/2016 - 12/2006
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2016 - 09/2015
2Sulfhydryl Compounds (Thiols)IBA
01/2016 - 04/2014
2Cysteine (L-Cysteine)FDA Link
01/2016 - 09/2006
2Heparin (Liquaemin)FDA LinkGeneric
11/2014 - 11/2014
2AntigensIBA
11/2014 - 07/2007
2A-Form DNA (A-DNA)IBA
11/2014 - 04/2011
2Carbon Nanotubes (Carbon Nanotube)IBA
08/2014 - 01/2014
2Bovine Serum AlbuminIBA
04/2014 - 01/2008
2EnzymesIBA
02/2012 - 05/2002
2Therapeutic UsesIBA
12/2009 - 09/2003
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2009 - 01/2008
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2009 - 01/2008
2HydrogelsIBA
07/2009 - 09/2007
2MicellesIBA
05/2009 - 12/2005
2Transcription Factors (Transcription Factor)IBA
08/2008 - 02/2007
2Lipid PeroxidesIBA
01/2008 - 11/2006
2Superoxide DismutaseIBA
01/2008 - 06/2006
2ethylenediamine (ethylenediamine dihydroiodide)FDA Link
09/2007 - 05/2007
2lysyl- arginyl- threonyl- glycyl- glutaminyl- tyrosyl- lysyl- leucyl- cysteineIBA
06/2007 - 09/2006
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2007 - 09/2006
21,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
11/2006 - 02/2006
2CholesterolIBA
11/2006 - 02/2006
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2022
1propylene (propene)IBA
09/2021
1tetrafluoroethylene (tetrafluoroethene)IBA
09/2021
1Elastomers (Elastomer)IBA
09/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2020
1NucleosidesIBA
09/2019
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
09/2019
1Reverse Transcriptase InhibitorsIBA
09/2019
1Protease Inhibitors (Protease Inhibitor)IBA
09/2019
1IntegrasesIBA
09/2019
1Paclitaxel (Taxol)FDA LinkGeneric
04/2019
1Radioisotopes (Radionuclides)IBA
07/2018
1E-SelectinIBA
01/2017
1APTIBA
01/2016
1CationsIBA
01/2016

Therapy/Procedure

15Therapeutics
11/2020 - 12/2005
10Intravenous Injections
11/2009 - 09/2003
4Immunotherapy
11/2014 - 03/2008
3Precision Medicine
07/2020 - 06/2015
3Drug Therapy (Chemotherapy)
09/2019 - 03/2008
3Intraperitoneal Injections
04/2014 - 01/2006
3Intravenous Administration
03/2009 - 09/2003
2Injections
09/2013 - 02/2012
2Intranasal Administration
01/2012 - 01/2010
2Operative Surgical Procedures
01/2008 - 11/2006
1Lab-On-A-Chip Devices
09/2021